FDA.reportPublic FDA data

rituximab-pvvr 100 MG per 10 ML Injection

RxCUI
2273512
RxNorm name
rituximab-pvvr 100 MG per 10 ML Injection
Display name
rituximab-pvvr 100 MG per 10 ML Injection
Full name
rituximab-pvvr 100 MG per 10 ML Injection
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:29

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761103Ruxiencerituximab-pvvr351(k) BiosimilarRx2026-07-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
RuxienceRITUXIMAB-PVVRPfizer Laboratories Div Pfizer Incf941fc61-f7a3-4e4a-ab7c-87c1667fa05b2026-04-08Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2273512

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
f941fc61-f7a3-4e4a-ab7c-87c1667fa05briTUXimab-pvvr 100 MG in 10 ML Injection [PSN] · 10 ML rituximab-pvvr 10 MG/ML Injection [SCD] · rituximab-pvvr 100 MG per 10 ML Injection [SY]311These highlights do not include all the information needed to use RUXIENCE safely and effectively. See full prescribing information for RUXIENCE. RUXIENCE ® (rituximab-pvvr) injection, for intravenous use Initial U.S. Approval: 2019 RUXIENCE (rituximab-pvvr) is biosimilar Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and that there are no clinically meaningful differences bet20260408